Author:
Mavroeidi Panagiou,Zorba Leandros P.,Tzouras Nikolaos V.,Neofotistos Stavros P.,Georgiou Nikitas,Sahin Kader,Senturk Murat,Durdagi Serdar,Vougioukalakis George,Mauromoustakos Thomas
Reference62 articles.
1. Synthesis and Reactivity of Propargylamines in Organic Chemistry;K Lauder;Chem. Rev,2017
2. ASS234 As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy;J Marco-Contelles;Front. Neurosci,2016
3. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration;J Z Wang;J. Alzheimers Dis,2013
4. Propargylamine as functional moiety in the design of multifunctional drugs for neurodegenerative disorders: MAO inhibition and beyond;F T Zindo;Future Med. Chem,2015
5. Role of Monoamine Oxidase Activity in Alzheimer's Disease: An Insight into the Therapeutic Potential of Inhibitors;T Behl;Molecules,2021